Skip to content

Price / sales at other companies

CVS Health logo
CVS HealthCVS
0.2×0.0×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
0.6×+0.3×
Universal Health Services logo
Universal Health ServicesUHS
0.6×-0.1×
Encompass Health Corporation logo
Encompass Health CorporationEHC
1.6×-0.3×
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
5.1×+0.8×
HCA Healthcare logo
HCA HealthcareHCA
1.4×+0.2×

Other financials

Income statement

See full
Revenue$403.5M+21.2%
Operating income$22.3M+1,289%
Net income$14.2M+1,909%
EPS (diluted)$0.04

Balance sheet

See full
Cash & equivalents$194.8M+45.0%
Total debt$476.8M-1.1%
Total equity$1.5B+1.4%
Total assets$2.1B+2.0%

Cash flow

See full
Operating cash flow$33.1M+1,171%
CapEx$10.8M+50.2%
Free cash flow$22.3M+318%

Valuation

See full
Market cap$3.43B-4.8%
Enterprise value$3.71B-6.5%
P/E147.8×

Profitability

See full
Operating margin3%+2.4pp
Net margin1.6%+1.0pp
FCF margin9.5%+1.6pp

Returns & leverage

See full
Return on equity1.6%+1.0pp
Debt / equity0.3×0.0×
Current ratio1.5×0.0×

Where this comes from

Calculated from LifeStance Health Group’s reported figures.

Based on the most recent quarter.

The official record: LifeStance Health Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeStance Health Group's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeStance Health Group's price / sales?
LifeStance Health Group (LFST) reported price / sales of 1.6× in Q1 2026.
How has LifeStance Health Group's price / sales changed year-over-year?
LifeStance Health Group's price / sales decreased by 18.3% year-over-year, from 2× to 1.6×.
What is the long-term trend for LifeStance Health Group's price / sales?
Over 4 years (2021 to 2025), LifeStance Health Group's price / sales has grown at a -21.3% compound annual growth rate (CAGR), from 5× to 1.9×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.